Influence of the  COVID-19 on HCC Patients and its Reverberations

Vyshali J Gogi

国际标准期刊号: 2476-2253

癌症诊断杂志

开放获取

我们集团组织了 3000 多个全球系列会议每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 和 15,000,000 名读者每份期刊 获得 25,000 多名读者

出版政策和道德

索引于

谷歌学术
参考搜索
哈姆达大学
亚利桑那州EBSCO
普布隆斯
ICMJE

有用的链接

开放获取期刊

分享此页面

抽象的

Influence of the COVID-19 on HCC Patients and its Reverberations

Vyshali J Gogi*

The COVID-19 outbreak has affected worldwide in the grievous way. The victims of COVID-19 who are having
previous ailments are more prone to severe condition and death. Hepatocellular Carcinoma (HCC) is one such liver
cancer which needs timely treatment and care. HCC patients are more susceptible to severe Corona Virus infection
and should be treated with priority. The current work is a review on the influence of COVID-19 on HCC patients.

免责声明: 此摘要通过人工智能工具翻译，尚未经过审核或验证。